Patent · US Active

Ocular iontophoretic delivery of dexamethasone and formulations thereof

US10376463B2 · kind B2 · utility

5Cited by
20References
1Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 11, 2012
Grant dateAug 13, 2019
Priority date—
Expiry dateApr 29, 2033

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61N1/044
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Disclosed herein are formulations of dexamethasone or a prodrug thereof suitable for delivery by ocular iontophoresis and methods of use thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.